# Multi-Target Cardioprotection from Berberis kaschgarica Extract in Zebrafish via AMPK Pathway Activation

**Authors:** Alhar Baishan, Dilihuma Dilimulati, Alifeiye Aikebaier, Yipaerguli Paerhati, Xiaoxiao Qiu, Nazhakaiti Yusufujiang, Yilixiati Wusiman, Adili Abudoureheman, Wenting Zhou

PMC · DOI: 10.3390/antiox15020253 · Antioxidants · 2026-02-14

## TL;DR

A plant extract from Berberis kaschgarica protects zebrafish hearts by reducing stress and inflammation, possibly through activating a key energy pathway.

## Contribution

This study reveals the cardioprotective mechanisms of Berberis kaschgarica extract in heart failure via AMPK pathway activation.

## Key findings

- BKRE contains 14 bioactive compounds with antioxidant properties and drug-like qualities.
- BKRE improves heart function in zebrafish by reducing oxidative stress and inflammation.
- BKRE activates the AMPK-PPARα-PGC-1α pathway, offering multi-target cardioprotection.

## Abstract

Background: Heart failure (HF) has a complex pathogenesis involving oxidative stress, inflammation, and energy metabolism disorders, and requires multi-target agents. Berberis kaschgarica Rupr. (BKR) is used in Uyghur folk medicine to improve cardiovascular health, but its cardioprotective mechanisms against HF remain unclear. Methods: UPLC-MS/MS was used to identify BKRE components; DPPH/ABTS assays evaluated antioxidant activity. The MTC of BKRE was determined in zebrafish, and its effects on ISO-induced HF zebrafish were assessed via cardiac function, apoptosis, oxidative stress, and inflammation indicators. Network pharmacology, molecular docking, transcriptomics, and qRT-PCR clarified targets and pathways. Results: BKRE contained 14 bioactive flavonoids/alkaloids with favorable drug-likeness, showing concentration-dependent DPPH and ABTS scavenging. In HF zebrafish, BKRE (5/10/20 μg/mL) dose-dependently improved cardiac function, inhibited apoptosis, reduced ROS and TNF-α/IL-6, restored GSH/T-SOD, activated the AMPK-PPARα-PGC-1α pathway by binding ALOX5/NQO1, etc. Conclusions: BKRE exerts multi-mechanistic cardioprotective effects, validating BKR’s ethnopharmacological value and highlighting it as a promising HF agent/functional food.

## Linked entities

- **Proteins:** PRKAA1 (protein kinase AMP-activated catalytic subunit alpha 1), PPARA (peroxisome proliferator activated receptor alpha), PPARGC1A (PPARG coactivator 1 alpha), ALOX5 (arachidonate 5-lipoxygenase), NQO1 (NAD(P)H quinone dehydrogenase 1), TNF (tumor necrosis factor), IL6 (interleukin 6), LOC23687505 (pyrimidodiazepine synthase)
- **Chemicals:** ABTS (PubChem CID 35688)
- **Diseases:** heart failure (MONDO:0005252), HF (MONDO:0015193)
- **Species:** Danio rerio (taxon 7955)

## Full-text entities

- **Genes:** nqo1 (NAD(P)H dehydrogenase, quinone 1) [NCBI Gene 322506] {aka wu:fb63c10, zgc:77191}, esr1 (estrogen receptor 1) [NCBI Gene 259252] {aka ER[a], ESR, NR3A1, abrrl, eralpha, zfER[a]}, src (SRC proto-oncogene, non-receptor tyrosine kinase) [NCBI Gene 325084] {aka c-src, fc54g04, p60-Src, sb:cb864, wu:fc54g04}, pparaa (peroxisome proliferator-activated receptor alpha a) [NCBI Gene 563298] {aka ppara3, si:ch211-239e6.3}, il6 (interleukin 6 (interferon, beta 2)) [NCBI Gene 100885851], fbxo5 (F-box protein 5) [NCBI Gene 445392] {aka emi1, fc65h02, wu:fc65h02, wu:fe06e07, wu:fz79f03, zgc:136397}, PDE5A (phosphodiesterase 5A) [NCBI Gene 8654] {aka CGB-PDE, CN5A, PDE5}, actb1 (actin, beta 1) [NCBI Gene 57934] {aka ACTB, B-ACTZF, actba, bact, bactin1, bactzf}, alox5ap (arachidonate 5-lipoxygenase-activating protein) [NCBI Gene 337376] {aka wu:fj65d02, zgc:63982}, alox5b.1 (arachidonate 5-lipoxygenase b, tandem duplicate 1) [NCBI Gene 573013] {aka alox5, si:dkey-77f5.12}, mtor (mechanistic target of rapamycin kinase) [NCBI Gene 324254] {aka frap1, tor, wu:fc22h08}, cat (catalase) [NCBI Gene 30068] {aka fb68a12, wu:fb68a12}, egfra (epidermal growth factor receptor a (erythroblastic leukemia viral (v-erb-b) oncogene homolog, avian)) [NCBI Gene 378478] {aka EGFR12, EGFR15, egfr}, tnfa (tumor necrosis factor a (TNF superfamily, member 2)) [NCBI Gene 405785], ALOX5 (arachidonate 5-lipoxygenase) [NCBI Gene 240] {aka 5-LO, 5-LOX, 5LPG, LOG5}, pde5ab (phosphodiesterase 5A, cGMP-specific, b) [NCBI Gene 553270] {aka PDE5, pde5a}, akt1 (AKT serine/threonine kinase 1) [NCBI Gene 101910198], NQO1 (NAD(P)H quinone dehydrogenase 1) [NCBI Gene 1728] {aka DHQU, DIA4, DTD, NMOR1, NMORI, QR1}, pparab (peroxisome proliferator-activated receptor alpha b) [NCBI Gene 557714] {aka PPAR[a], ppara, ppara1, pparal}, ALOX5AP (arachidonate 5-lipoxygenase activating protein) [NCBI Gene 241] {aka FLAP}, ppargc1a (peroxisome proliferator-activated receptor gamma, coactivator 1 alpha) [NCBI Gene 553418] {aka PGC-1, PGC-1alpha, PGC1, gb:dq017637, ppargc1al}, PLA2G2A (phospholipase A2 group IIA) [NCBI Gene 5320] {aka MOM1, PLA2, PLA2B, PLA2L, PLA2S, PLAS1}, hk2 (hexokinase 2) [NCBI Gene 406339] {aka fi09d05, fi17h06, wu:fi09d05, wu:fi17h06, wu:fi31b04, zgc:55926}, pfkla (phosphofructokinase, liver a) [NCBI Gene 570106]
- **Diseases:** toxicity (MESH:D064420), cardiovascular complications (MESH:D002318), atrioventricular dilation (MESH:D002311), acute myocardial infarction (MESH:D009203), myocardial ischemia (MESH:D017202), cardiac output reduction (MESH:D002303), death (MESH:D003643), Hypertension (MESH:D006973), retention (MESH:D016055), overdose (MESH:D062787), impairment of myocardial functions (MESH:D003072), MTC (MESH:D018149), Malformation (MESH:C564254), cardiac remodeling (MESH:D020257), cardiac hypertrophy (MESH:D006332), cardiac dysfunction (MESH:D006331), infarction (MESH:D007238), CHF (MESH:D006333), ventricular dysfunction (MESH:D018754), edema (MESH:D004487), ischemic (MESH:D002545), inflammation (MESH:D007249), injury to (MESH:D014947), hypoxia (MESH:D000860), OMIM (MESH:D030342), metabolic dysfunction (MESH:D008659), cardiac ischemia (MESH:D007511), cardiotoxicity (MESH:D066126), Myocardial Injury (MESH:D009202), myocardial energy metabolism disorders (MESH:D011502), Cardiac edema (MESH:D004489), arrhythmias (MESH:D001145)
- **Chemicals:** hydroxylamine (MESH:D019811), Tetrandrine (MESH:C009438), DCF (MESH:D015649), Diosmetin (MESH:C039602), superoxide (MESH:D013481), 2,2'-azino-bis(3-ethylbenzothiazoline-6-sulfonate) (-), Flavonoids (MESH:D005419), Baicalein (MESH:C006680), ROS (MESH:D017382), tricaine methane sulfonate (MESH:C003636), Luteolin (MESH:D047311), PBS (MESH:D007854), H (MESH:D006859), Isocorydine (MESH:C030168), ABTS (MESH:C002502), lipid (MESH:D008055), agarose (MESH:D012685), ISO (MESH:D007545), BCA (MESH:C047117), peroxynitrite (MESH:D030421), GSH (MESH:D005978), acetonitrile (MESH:C032159), 2,2-diphenyl-1-picrylhydrazyl (MESH:C004931), 2',7'-dichlorodihydrofluorescein diacetate (MESH:C110400), Nobiletin (MESH:C008661), nitrogen (MESH:D009584), formic acid (MESH:C030544), oxygen (MESH:D010100), AO (MESH:D000165), metal (MESH:D008670), NO (MESH:D009569), ethanol (MESH:D000431), hydroxyl (MESH:D017665), Oripavine (MESH:C005283), Tangeretin (MESH:C059006), VC (MESH:D001205), alkaloid (MESH:D000470), DCFH-DA (MESH:C029569), Dihydroberberine (MESH:C039639), TRIzol (MESH:C411644), water (MESH:D014867), Kaempferol (MESH:C006552)
- **Species:** Homo sapiens (human, species) [taxon 9606], Danio rerio (leopard danio, species) [taxon 7955], Berberis kaschgarica (species) [taxon 1720320]
- **Cell lines:** AN121-1 — Homo sapiens (Human), Ovarian carcinosarcoma, Cancer cell line (CVCL_G294), E-EL- — Homo sapiens (Human), Breast adenocarcinoma, Cancer cell line (CVCL_0C08)

## Full text

_Full body text omitted from this summary view._ Fetch the complete paper as Markdown: https://tomesphere.com/paper/PMC12938539/full.md

## Figures

13 figures with captions in the complete paper: https://tomesphere.com/paper/PMC12938539/full.md

## References

36 references — full list in the complete paper: https://tomesphere.com/paper/PMC12938539/full.md

---
Source: https://tomesphere.com/paper/PMC12938539